NASDAQ:HRTX

Heron Therapeutics Stock Insider Trading

etoro logo Buy HRTX
*Your capital is at risk
$0.496
-0.0012 (-0.241%)
At Close: Jul 31, 2026

Heron Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.99. In total, the insiders bought 14.27M and sold 100.37K HRTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.99
Buy 14.27M shares
Sell 100.37K shares
96% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 30, 2026
Buy
Restricted Stock Units
M-Exempt
Forbes William P
EVP, Chief Development Officer
Officer 11 694
Value: $14.0K
Apr 30, 2026
Buy
Common Stock
M-Exempt
Duarte Ira
EVP, Chief Financial Officer
C-Suite Officer 11 694
Value: $14.0K
Apr 30, 2026
Buy
Common Stock
M-Exempt
Collard Craig A
Chief Executive Officer
CEO / President 50 021
Value: $60.0K
Apr 30, 2026
Buy
Restricted Stock Units
M-Exempt
Collard Craig A
Chief Executive Officer
CEO / President 50 021
Value: $60.0K
Apr 19, 2026
Buy
Restricted Stock Units
M-Exempt
Duarte Ira
EVP, Chief Financial Officer
C-Suite Officer 3 874
Value: $2K
Apr 19, 2026
Buy
Common Stock
M-Exempt
Duarte Ira
EVP, Chief Financial Officer
C-Suite Officer 3 874
Value: $2K
Apr 19, 2026
Buy
Restricted Stock Units
M-Exempt
Collard Craig A
Chief Executive Officer
CEO / President 13 797
Value: $7K
Apr 19, 2026
Buy
Common Stock
M-Exempt
Collard Craig A
Chief Executive Officer
CEO / President 13 797
Value: $7K
Apr 19, 2026
Buy
Restricted Stock Units
M-Exempt
Forbes William P
EVP, Chief Development Officer
Officer 3 874
Value: $2K
Apr 19, 2026
Buy
Common Stock
M-Exempt
Forbes William P
EVP, Chief Development Officer
Officer 3 874
Value: $2K
Apr 03, 2026
Buy
Common Stock
M-Exempt
Collard Craig A
Chief Executive Officer
CEO / President 62 500
Value: $31.0K
Apr 03, 2026
Buy
Restricted Stock Units
M-Exempt
Collard Craig A
Chief Executive Officer
CEO / President 62 500
Value: $31.0K
Jan 31, 2026
Buy
Common Stock
M-Exempt
Duarte Ira
EVP, Chief Financial Officer
C-Suite Officer 11 695
Value: $6K
Jan 31, 2026
Buy
Restricted Stock Units
M-Exempt
Duarte Ira
EVP, Chief Financial Officer
C-Suite Officer 11 695
Value: $6K
Jan 31, 2026
Buy
Common Stock
M-Exempt
Forbes William P
EVP, Chief Development Officer
Officer 11 695
Value: $6K
Jan 31, 2026
Buy
Restricted Stock Units
M-Exempt
Forbes William P
EVP, Chief Development Officer
Officer 11 695
Value: $6K
Jan 31, 2026
Buy
Common Stock
M-Exempt
Collard Craig A
Chief Executive Officer
CEO / President 34 789
Value: $17.3K
Jan 31, 2026
Buy
Restricted Stock Units
M-Exempt
Collard Craig A
Chief Executive Officer
CEO / President 34 789
Value: $17.3K
Jan 30, 2026
Buy
Common Stock
A-Award
Morgan Adam
Director
Director 53 960
Value: $71.2K
Jan 30, 2026
Buy
Performance Stock Units
A-Award
Hensley Mark Earl
Chief Operating Officer
C-Suite Officer 188 314
Value: $248.6K
Jan 30, 2026
Buy
Restricted Stock Units
A-Award
Hensley Mark Earl
Chief Operating Officer
C-Suite Officer 188 315
Value: $248.6K
Jan 30, 2026
Buy
Common Stock
A-Award
Dissanaike Sharmila
Director
Director 53 960
Value: $71.2K
Jan 30, 2026
Buy
Performance Stock Units
A-Award
Forbes William P
EVP, Chief Development Officer
Officer 188 314
Value: $248.6K
Jan 30, 2026
Buy
Restricted Stock Units
A-Award
Forbes William P
EVP, Chief Development Officer
Officer 188 315
Value: $248.6K
Jan 30, 2026
Buy
Performance Stock Units
A-Award
Duarte Ira
EVP, Chief Financial Officer
C-Suite Officer 216 561
Value: $285.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT HERON THERAPEUTICS
Heron Therapeutics
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE